• Pediatrics / Primary Care Pediatrics
• Pediatrics / Infectious Diseases

Address:
DUMC 3675
Durham, NC 27710

Appointment Telephone:
919-620-5333

Office Telephone:
919-620-5374

Fax Telephone:
919-471-3820

• MD, University of Maryland School of Medicine, 1983

• Pediatrics, University of Maryland, 1983-1986

• Pediatric Infectious Diseases, Duke University Medical Center, 1987-1990

• MPH, University of North Carolina at Chapel Hill, 1992

Clinical Interests:
General pediatrics, infectious diseases in children, vaccine research

Research Interests:
Dr. Emmanuel (Chip) B. Walter is Director of the Duke Translational Medicine Institute Clinical Vaccine Unit and he is Associate Director of the Primary Care Research Consortium at the Duke Clinical Research Institute.

Vaccine research:
  Clinical Trials (smallpox vaccines, pandemic and seasonal influenza virus vaccines, investigational respiratory virus vaccines, rotavirus vaccine, human papilloma virus vaccine,  conjugate pneumococcal vaccine, conjugate meningococcal vaccines, combination vaccines)

  Vaccine utilization (influenza vaccination of special populations, adolescent immunization)

Epidemiologic studies:
  National Children's Study

Representative Publications:
Mast TC, Demuro-Mercon C, Kelly CM, Floyd LE, Walter EB. The impact of rotavirus gastroenteritis on the family.  BMC Pediatr.  2009 Feb 6;9(1):11. (2009) Abstract

Walter EB, Snyder MA, Clements DA, Katz SL. Large injection site reactions after a second dose of varicella vaccine.  Pediatr Infect Dis J.  2008 Aug;27(8):757-9. (2008) Abstract

Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.  Vaccine.  2008 Jul 29;26(32):4057-61. (2008) Abstract

Keitel WA, Campbell JD, Treanor JJ, Walter EB, Patel SM, He F, Noah DL, Hill H. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.  J Infect Dis.  2008 Nov 1;198(9):1309-16. (2008) Abstract

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?  Pediatrics.  2006 Sep;118(3):e570-8. (2006) Abstract

Guerra FA, Gress J, Werzberger A, Reisinger K, Walter E, Lakkis H, Grosso AD, Welebob C, Kuter BJ,  . Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.  Pediatr Infect Dis J.  2006 Oct;25(10):912-9. (2006) Abstract

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.  Pediatrics.  2006 Sep;118(3):e579-85. (2006) Abstract

Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.  Pediatrics.  2005 Apr;115(4):1039-47. (2005) Abstract

Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan M, Heaton P. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J. 2003 Oct;22(10):914-20. (2003) Abstract

Wilson TE, Ickovics JR, Fernandez MI, Koenig LJ, Walter E,  . Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states.  Am J Obstet Gynecol.  2001 May;184(6):1235-40. (2001) Abstract

Walter EB, Royce RA, Fernández MI, DeHovitz J, Ickovics JR, Lampe MA, . New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstet Gynecol. 2001 Jan;97(1):70-6. (2001) Abstract

Royce RA, Walter EB, Fernandez MI, Wilson TE, Ickovics JR, Simonds RJ,  . Barriers to universal prenatal HIV testing in 4 US locations in 1997.  Am J Public Health.  2001 May;91(5):727-33. (2001) Abstract

Fernández MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep. 2000 Sep-Oct;115(5):460-8. (2000) Abstract

Walter EB, Hornick RB, Poland GA, Tucker R, Bland CL, Clements DA, Rhamstine CC, Jacobson RM, Brown L, Gress JO, Harris KE, Wiens BL, Nalin DR. Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults.  Vaccine.  1999 Mar 17;17(11-12):1468-73. (1999) Abstract

Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995 Oct;149(10):1113-7. (1995) Abstract